300 related articles for article (PubMed ID: 36618348)
1. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
3. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
Hong J; Wang X; Yu L; Li J; Hu H; Mao W
J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
[TBL] [Abstract][Full Text] [Related]
4. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
5. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
6. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
He L; Yang H; Huang J
BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
8. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
9. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
10. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
11. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract][Full Text] [Related]
12. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
13. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
14. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
15. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma.
Feng J; Wang J; Xu Y; Lu F; Zhang J; Han X; Zhang C; Wang G
PLoS One; 2023; 18(7):e0288180. PubMed ID: 37405988
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma.
Mao X; Song F; Jin J; Zou B; Dai P; Sun M; Xu W; Wang L; Kang Y
Front Immunol; 2023; 14():1202725. PubMed ID: 37465666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]